Medicare Will Pay $50K For Your Heart Attack. It Should Pay $100 To Prevent It
AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

Updated ACC/AHA guidance issued in March 2026 gives coronary artery calcium scans a central role when preventive treatment decisions remain uncertain for adults at borderline or intermediate risk. The test can help assess plaque and guide discussions about prevention, but the source does not establish that Medicare will cover it for $100 or that scans prevent heart attacks in every patient.

The American College of Cardiology and American Heart Association gave coronary artery calcium scans a central role in their March 2026 heart-disease prevention guidelines, recommending the test for some adults at borderline or intermediate risk when a decision about preventive treatment remains uncertain. The change addresses a gap between risk estimates and imaging that can detect calcified plaque, but it does not, by itself, establish Medicare coverage or a $100 payment rate.

In an October 25, 2026, opinion report for MedPage Today, cardiologists Arthur Agatston and Oren Mechanic discuss the guidelines’ role in CAC testing. A CAC scan uses a CT image to detect and measure calcified plaque in the coronary arteries. The authors report that the scan takes about 10 minutes, costs roughly $100 when paid out of pocket, and uses a fraction of the radiation of a standard chest CT.

The recommendation applies when a clinician and patient are uncertain whether to begin preventive treatment, such as a statin. Traditional risk calculators estimate the likelihood of cardiovascular disease using factors such as age, cholesterol, blood pressure, diabetes and smoking; a CAC scan can provide an image-based measure of calcified plaque. The authors say a score of zero can support reclassifying a patient’s risk downward, while a score above 100 may indicate that medication and intensive lifestyle measures could be appropriate. Treatment decisions still require clinical judgment.

As an example, the authors describe a 52-year-old patient, identified by a changed name, whose standard risk estimate was low but whose CAC score was 220. They say the finding changed the prevention discussion. This individual case does not establish the test’s effect across a population. The article’s headline contrasts a claimed $50,000 heart-attack cost with a roughly $100 scan, but the report does not provide a Medicare payment policy or a detailed source for that comparison.

At a glance
reportWhen: Guidelines issued March 2026; opinion r…
The developmentThe ACC and AHA’s March 2026 prevention guidelines gave coronary artery calcium scans a central role for certain adults whose need for preventive treatment is uncertain.

A Scan Can Inform Prevention Decisions

The guideline change may affect how clinicians approach patients whose risk is not clearly high or low. A scan that detects plaque can provide additional information when a clinician and patient consider the potential benefits of preventive medication. According to the report’s description of the guidance, a zero score may help some patients avoid medication they might otherwise start.

Access is a separate issue. Agatston and Mechanic say patients often pay cash for CAC testing because insurance coverage can constrain its use. The source does not document a new Medicare benefit, a national reimbursement rate, or a policy change tied to the March guidelines. A recommendation in clinical guidance does not automatically establish coverage or affordability for every eligible patient.

From Risk Scores to Plaque Imaging

Prevention decisions have commonly relied on calculators that estimate risk from population-level factors. CAC imaging provides different information by showing calcified coronary plaque. The authors say evidence for the scan accumulated over more than 30 years, while national guidelines had previously included it only peripherally. The March 2026 recommendation changes its place in guidance; it does not say that imaging should replace standard risk assessment for everyone.

The report also discusses artificial intelligence tools that can identify calcification on chest CT scans obtained for other reasons. The authors say these tools could help flag people for further cardiovascular evaluation, including patients who might not seek a separate paid scan. The article does not provide results establishing how widely such systems are used or whether they improve health outcomes.

“when possible, measure the disease”

— Arthur Agatston and Oren Mechanic, writing in MedPage Today

Coverage and Outcomes Still Unsettled

The source does not show whether Medicare pays $50,000 for a heart attack or would cover a CAC scan for $100. Those figures appear in the opinion piece’s headline and framing; they are not presented there as a specific Medicare reimbursement decision. Coverage may depend on policy and circumstances, and readers should not infer a universal benefit from the guideline recommendation.

The report does not quantify how many heart attacks CAC screening would prevent or establish that screening reduces heart attacks or deaths across all patients offered a scan. It describes the test as useful for selected decisions and cites an illustrative patient. The extent of insurance coverage, the use of AI-based analysis, and the effects of broader scanning remain unclear from the material provided.

How Guidance Reaches Clinical Practice

Implementation will involve clinicians and health systems applying the updated recommendation to patients whose treatment decisions remain uncertain, while considering individual risks and preferences. The report does not identify a new federal payment rule or a scheduled Medicare action. Patients considering a scan can ask their clinician whether they fit the guideline’s intended group and check their insurer’s coverage before testing.

Further evidence and policy decisions will determine whether CAC scanning becomes more accessible and whether AI can reliably identify people who need follow-up. Based on the material provided, the documented change is the scan’s expanded role in professional prevention guidance, not a guaranteed payment arrangement or a universal screening mandate.

Key Questions

What changed in the 2026 heart-disease guidelines?

The ACC and AHA gave CAC scans a central role for adults at borderline or intermediate risk when the decision about preventive treatment remains uncertain.

Does Medicare now pay $100 for a CAC scan?

The source does not establish a Medicare payment rate or a new coverage policy. It reports an approximate $100 out-of-pocket cost for the scan.

What does a coronary calcium scan show?

A CAC scan uses CT imaging to detect and measure calcified plaque in the coronary arteries. It can add information to a clinician’s assessment of cardiovascular risk.

Does a zero score mean someone cannot have a heart attack?

No. The report says a score of zero can reclassify risk downward, but it does not mean a person has no cardiovascular risk or guarantee that a heart attack will not occur. Discuss results with a qualified clinician.

Will a CAC scan prevent a heart attack?

The scan itself detects plaque; it does not prevent an event. Its potential value is helping guide preventive decisions. The source does not quantify how many heart attacks screening prevents across a population.

Source: medpagetoday.com

This article is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional about your specific situation.
You May Also Like

Kyntra Bio Surges In Global Coverage

Search interest in Kyntra Bio has spiked, with 17 mentions this week, indicating rising global attention amid unconfirmed developments.

Sudarshan Pharma Surges In Global Coverage

Sudarshan Pharma experiences a surge in international coverage, with media mentions increasing tenfold in recent days, signaling rising global interest.

Zimmer Biomet Surges In Global Coverage

Zimmer Biomet experiences a surge in international coverage, with media mentions increasing significantly, signaling heightened industry interest.

Pfizer Surges In Global Coverage

Pfizer’s media mentions have surged significantly worldwide, marking a major shift in its public and media attention. Details on causes and implications are emerging.